vasoconstrictor (Otrivin)

PreclinicalSmall molecule

UUniversity of Electronic Science and Technology of China

vasoconstrictor (Otrivin) is one of 2 small molecule programs targeting Emotional Processing. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Emotional ProcessingRecruiting

Emotional ProcessingPreclinical

Recruiting

Competition

Competitive Landscape

3 competitors in Emotional Processing

#DrugCompanyPhaseTrials

D-Cycloserine

MMassachusetts General Hospital

Preclinical

1 2

vasoconstrictor (Otrivin)

UUniversity of Electronic Science and Technology of China

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Emotional Processing1 trial

Oxytocin's Effects on Emotional Processing and Its Acting Routes

Recruiting·UUniversity of Electronic Science and Technology of China·N/A·NCT07425938·120 enrolled

Oxytocin1 trial

Comparison of Intranasal Oxytocin Effects Using Co-administration With a Vasoconstrictor

Completed·UUniversity of Electronic Science and Technology of China·N/A·NCT04134663·96 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for vasoconstrictor (Otrivin). U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — vasoconstrictor (Otrivin) compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for vasoconstrictor (Otrivin). EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Electronic Science and Technology of China company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: UUniversity of Electronic Science and Technology of China

vasoconstrictor (Otrivin)

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Emotional Processing1 trial

Oxytocin1 trial

References

Drug Info

Quick Facts

Related News